Trial Profile
Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II/III
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Losartan (Primary) ; Metoprolol
- Indications Essential hypertension
- Focus Pharmacodynamics
- 05 Jul 2012 Actual initiation date (Sep 2005), lead trial centre and investigator added as reported by ClinicalTrials.gov.
- 05 Jul 2012 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
- 05 Jul 2012 Status changed from completed to withdrawn prior to recruitment as reported by ClinicalTrials.gov.